(S1 (S (NP (NN LMP1)) (VP (VBZ Promotes) (NP (NP (NN B-1a) (NNS Lymphomas)) (SBAR (WHNP (WDT That)) (S (VP (MD Can) (VP (VB Escape) (NP (JJ Allelic) (NN Exclusion))))))))))
(S1 (S (NP (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-)) (NP (NN Flow) (NN cytometry) (NN analysis)) (PP (IN of) (NP (NP (NNS splenocytes)) (PP (IN from) (NP (DT a) (NN WT) (CC or) (NN LMP1) (JJ transgenic) (NN lymphoma))))) (PP (IN for) (NP (NP (NP (DT the) (NN pan-B) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN CD19)) (-RRB- -RRB-))) (, ,) (NP (NP (NN B-1a) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN CD5)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NP (NP (NN Ig) (JJ heavy) (NN chain)) (PRN (-LRB- -LRB-) (NP (NP (NN IgM)) (CC and) (NP (NN IgD))) (-RRB- -RRB-))) (CC and) (NP (NN light) (NN chain))) (PRN (-LRB- -LRB-) (NP (NP (NN kappa)) (CC and) (NP (NN lambda))) (-RRB- -RRB-))) (NNS markers)))) (. .))))
(S1 (S (S (NP (VBN Shown)) (VP (VBP are) (NP (NP (DT the) (NNS results)) (PP (IN from) (NP (NP (NN WT) (NN lymphoma) (CD 1)) (CC and) (NP (NN LMP1) (JJ transgenic) (NN lymphoma) (CD 4))))))) (. .)))
(S1 (S (S (NP (DT This) (NN analysis)) (VP (VBD was) (VP (VBN repeated) (PP (IN on) (NP (NP (NP (CD four) (JJ other) (NN LMP1) (JJ transgenic) (NNS lymphomas)) (PRN (-LRB- -LRB-) (QP (CD 1) (, ,) (CD 2) (, ,) (CD 3) (, ,) (CC and) (CD 6)) (-RRB- -RRB-))) (VP (VBG showing) (NP (NP (DT a) (JJ similar) (NN B-1a) (NN phenotype)) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (NNS lymphomas) (CD 2) (CC and) (CD 4)) (VP (VBD were) (ADVP (RB also)) (ADJP (RB doubly) (JJ positive) (PP (IN for) (NP (NN kappa) (CC and) (NN lambda) (NN light) (NNS chains)))))))))))))) (. .)))
(S1 (S (NP (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-)) (NP (NN Flow) (NN cytometry) (NN analysis)) (PP (IN of) (NP (NP (NP (NN WT)) (CC or) (NP (NN LMP1))) (JJ transgenic) (NNS splenocytes))) (PP (IN for) (NP (NP (NP (NN B-1a)) (PRN (-LRB- -LRB-) (NP (NN CD19+CD5+)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN B-1b)) (CC or) (NP (NN B2) (NNS subsets))) (PRN (-LRB- -LRB-) (NP (NN CD19+CD5-)) (-RRB- -RRB-))))) (. .))))
(S1 (S (S (NP (NP (NNS Percentages)) (PP (IN of) (NP (NP (NN B-1a)) (CC and) (NP (NN B-1b)) (CC or) (NP (NN B2)) (NP (NNS subsets))))) (VP (VBP are) (VP (VBN shown) (PP (IN in) (NP (DT each) (NN quadrant)))))) (. .)))
(S1 (S (S (NP (DT This) (NN analysis)) (VP (VBD was) (VP (VBN repeated) (PP (IN on) (NP (NP (NP (CD three) (JJ other) (JJ WT)) (CC and) (NP (CD two) (JJ other) (NN LMP1) (JJ transgenic) (NNS mice))) (PP (IN with) (NP (JJ similar) (NNS results)))))))) (. .)))
(S1 (S (S (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-)) (NP (NP (NN Immunoblot) (NN analysis)) (PP (IN for) (NP (NP (NP (NP (NN kappa)) (CC and) (NP (NN lambda))) (NN light) (NNS chains)) (PP (IN of) (NP (NP (NN B) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN CD19+)) (-RRB- -RRB-))))))) (VP (VBN purified) (PP (IN from) (NP (NP (NP (NN WT)) (CC and) (NP (NN LMP1))) (JJ transgenic) (NNS mice))))) (. .)))
(S1 (S (S (NP (NN Actin)) (VP (VBD was) (VP (VBN used) (PP (IN as) (NP (DT a) (NN loading) (NN control)))))) (. .)))
